| Variation name (cDNA level) | Variation name (protein level) | Variation status | Variation class |
| c.94_649del | p.Phe32MetfsX13 | Hemizygous | Mutation |
| wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
| TTT | Phe | del556a | Fs. | Stop at 44 | Fr. |
| Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
| Actin binding domain |
| At the mRNA level | On restriction map |
| New restriction site(s): none Lost restriction site(s): none |
| On isoforms (a blue cell indicates that the corresponding isoform is affected by the mutation) | ||||||
| Dp 427c | Dp 427m | Dp 427p | Dp 260 | Dp 140 | Dp 116 | Dp 71 |
| Immunofluorescence | ||||||
| dys 1 | dys 2 | dys 3 | ||||
| Irregular High | No signal with Revertant fibers | No signal | ||||
| Western Blot | ||
| dys 1 | dys 2 | dys 3 |
| Reduced size, low quantity (350 kDa) | No signal |
| Sample ID | Patient status | Gender | Transmission | Age of onset | Age of death | Geographic origin |
| ---102-0-41 | Proband | Male | Familial | FRANCE |
| Phenotypic group |
| BMD |
| Phenotype: either IMD or severe BMD. Mother : symptomatic, heart transplantation |
| Reference ID | Reference |
| 115 | Unpublished data |